Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See details about our updated masking policy »

Safety and technique of ferumoxytol administration for MRI. Magnetic resonance in medicine Vasanawala, S. S., Nguyen, K., Hope, M. D., Bridges, M. D., Hope, T. A., Reeder, S. B., Bashir, M. R. 2016; 75 (5): 2107-2111

Abstract

Ferumoxytol is an ultrasmall superparamagnetic iron oxide agent marketed for the treatment of anemia. There has been increasing interest in its properties as an MRI contrast agent as well as greater awareness of its adverse event profile. This mini-review summarizes the current state of knowledge of the risks of ferumoxytol and methods of administration. Magn Reson Med 75:2107-2111, 2016. © 2016 Wiley Periodicals, Inc.

View details for DOI 10.1002/mrm.26151

View details for PubMedID 26890830

View details for PubMedCentralID PMC4854636